In Defense Tech, Capital Is No Longer the Validation
Helsing raised $1.8 billion this week at an $18 billion valuation. A day later, Singularity emerged from stealth with an $80 million Series A to build lower-cost air-defense systems.
These are very different companies at very different stages.
But together, they tell us something important about defense technology:
Capital is no longer the primary constraint.
That is an encouraging development. It is also the point at which founders and investors need to become more disciplined.
Defense has crossed into the venture mainstream
Defense technology spent years outside mainstream venture.
Government sales cycles were considered too long. Hardware was considered too capital-intensive. Procurement was opaque. Many investors saw the category as fundamentally inconsistent with venture returns.
That has changed decisively.
PitchBook recorded $19.8 billion invested across 262 defense-tech deals in the first quarter of 2026. Helsing’s latest round included venture firms, growth investors, financial institutions and a major Canadian pension investor.
Capital is now entering defense from nearly every part of the private-market stack.
The obvious debate is whether this has created a defense-tech bubble.
I think that is the wrong level of analysis.
A good market can still contain bad investments
A sector can be structurally attractive and still contain badly underwritten companies.
Equally, a company can carry a high valuation and still be rationally financed if the capital materially increases its probability of becoming a category-defining platform.
Government demand may be rising. Procurement priorities may be changing. Software, autonomy and lower-cost manufacturing may be creating entirely new product categories.
None of that tells us whether a particular company is appropriately priced—or whether it is actually retiring the risks that stand between technical promise and commercial scale.
The right question is not whether defense technology is receiving too much capital.
It is what uncertainty each additional dollar of capital is retiring.
What is the next dollar actually buying?
In traditional software, a large financing might accelerate product development, customer acquisition and international expansion.
In defense, capital may need to do considerably more.
It can fund:
Technical development and testing
Certification and security requirements
Manufacturing facilities and inventory
Specialized engineering talent
Supply-chain resilience
Deployment and field support
The working capital required to serve government customers
These are legitimate reasons to raise large amounts of money. In some cases, capital itself becomes a competitive advantage because smaller companies simply cannot fund the required development and production cycle.
But fundraising can also blur the distinction between technical promise and commercial proof.
A company can use abundant capital to expand into more programs, build capacity before demand is established or postpone difficult decisions about which customer and product have the clearest path to scale.
Capital can retire risk. It can also finance unresolved risk for longer.
Knowing which is happening is the real underwriting challenge.
The milestones are not interchangeable
Defense companies progress through several distinct forms of validation:
Technical capability has been demonstrated.
The capability has been validated under operationally relevant conditions.
A customer has agreed to conduct a paid pilot or initial procurement.
The customer has made a repeat purchase.
The product has converted into a larger, enduring procurement program.
The company can deliver at the required cost, cadence and reliability.
These milestones may be directionally related. But they are not interchangeable.
A successful test is not a production contract.
A production contract is not a program of record.
A framework ceiling is not funded revenue.
Announced factory capacity is not demonstrated throughput.
Political support is not durable purchasing authority.
That distinction matters because the headline surrounding a defense company often collapses several of these milestones into a single impression: validation.
The underlying evidence may be much narrower.
Procurement remains procurement
Germany offers a useful example.
Its government approved an initial €540 million strike-drone order involving Helsing and Stark Defence. But lawmakers also reduced the proposed long-term procurement framework from €4.3 billion to €2 billion because they wanted to preserve parliamentary control over future commitments.
That is not evidence that demand is weak.
It is evidence that even in a period of strategic urgency, procurement remains procurement. Budgets, oversight, testing, performance, politics and competing priorities continue to matter.
A government can believe deeply in a mission while remaining cautious about a vendor, a program structure or the timing of a budget commitment.
Market urgency does not eliminate customer discipline.
What founders need to demonstrate
The weakest version of a defense startup’s narrative is:
Governments are spending more. Our technology is strategically important. Therefore, our market is large.
The stronger version is much more specific:
Which customer problem has been validated?
Under what operational conditions?
Who controls the relevant budget?
What must happen between the pilot and repeat procurement?
What production rate will the customer ultimately require?
What does the system cost per mission or engagement?
Which part of the product improves through deployment data?
What evidence would cause the customer to expand—or cancel—the program?
These questions are not obstacles to the founder’s vision.
They are the route by which the vision becomes a durable company.
Founders should be equally precise about the purpose of each financing round. “Scaling the company” is not enough.
The clearer question is: Which material risk should be measurably lower by the time this capital has been deployed?
What investors need to underwrite
The same discipline applies to investors.
Rising government budgets establish market attractiveness. They do not establish company quality.
A serious defense underwriting process should distinguish among at least five risks:
Technical performance
Operational validation
Procurement conversion
Production execution
Unit economics
Investors should then ask which of these risks have already been retired, which the new capital is expected to retire and which remain largely outside the company’s control.
This should also shape follow-on decisions.
A higher valuation is not evidence that the underlying risks have declined. Nor is a large new investor necessarily better informed about every part of the business.
Reserves should follow the retirement of risk, not simply the momentum of valuation.
Abundant capital changes company behavior
When capital is scarce, companies are forced to confront customer evidence early.
When capital is plentiful, they have more choices. They can pursue several products, enter multiple geographies, build manufacturing capacity ahead of demand and hire for programs that may still be uncertain.
Sometimes that ambition creates the platform.
Sometimes it creates an impressive collection of unresolved risks.
The distinction is especially important for early-stage investors. They cannot—and should not—compete with billion-dollar growth rounds on capital alone.
Their advantage must come from recognizing which teams are converting technical learning into customer trust faster than the market appreciates.
That may be a founder who understands the budget pathway as deeply as the technology.
It may be a company designing around cost per engagement rather than maximum technical performance.
It may be a software and autonomy layer that improves across several hardware platforms.
Or it may be a manufacturing process that creates a compounding data advantage with every deployed system.
These are more durable signals than the size of the next financing.
Helsing shows why the answer is not simple
Helsing’s development illustrates the nuance.
The company began with defense AI software and has expanded into strike drones, underwater systems, aircraft applications and manufacturing. It has now announced a West Virginia facility designed to produce more than 2,000 HX-2 drones per month.
That could create a powerful combination of software, hardware, operational data and industrial capacity.
It could also create a much larger execution surface.
The $1.8 billion financing gives Helsing the resources to pursue that ambition. The financing announcement alone cannot tell us whether each part of the strategy will produce durable value.
And that is precisely the point.
Capital is useful evidence of investor demand. It is not customer validation, manufacturing proof or confirmation of value accrual.
Strategic importance should raise the standard
Defense technology is becoming one of venture’s most important categories.
The founders building within it are addressing real and urgent problems. They should have access to serious capital.
But the strategic importance of the category should raise the standard of underwriting—not lower it.
In defense tech, capital can buy time, talent and industrial capacity. It cannot buy procurement truth.